Sorafenib Tablets
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
DLA TROOP SUPPORT
Contract Value
Not provided
Codes & Classification
Solicitation Number
SPE2D2-25-R-0016
NAICS
325412 - Pharmaceutical Preparation Manufacturing
Classification Code
6505
Additional Details
Documents3
The Defense Logistics Agency (DLA) Troop Support has issued a solicitation, identified as SPE2D2-25-R-0016, for the procurement of Sorafenib Tablets. This opportunity is classified under NAICS Code 325412, which pertains to Pharmaceutical Preparation Manufacturing, and is further designated by Product Service Code 6505, indicating its focus on drugs and biologicals.
The primary objective of this procurement is to secure a reliable supply of Sorafenib Tablets, a pharmaceutical product used in the treatment of certain types of cancer. The solicitation seeks qualified manufacturers or suppliers capable of meeting the stringent requirements associated with federal pharmaceutical contracts. The scope of the contract encompasses the manufacturing, packaging, and delivery of Sorafenib Tablets in accordance with applicable regulatory standards and DLA specifications. The intended outcome is to ensure uninterrupted availability of this critical medication for military and federal healthcare beneficiaries.
Key requirements for this solicitation include compliance with all relevant FDA regulations and Good Manufacturing Practices (GMP), as well as adherence to DLA Troop Support’s quality assurance protocols. Offerors are expected to demonstrate their capacity for consistent production, timely delivery, and robust quality control. The deliverables will consist of Sorafenib Tablets supplied in specified quantities and packaging formats, as detailed in the solicitation documents available on SAM.gov.
DLA Troop Support, a federal office, is the contracting entity responsible for this procurement. Interested parties may direct inquiries to the designated contacts: Ryan Guarnere ([email protected], 445-737-1729) and Catherine Gilbert ([email protected], 445-737-8868). The solicitation was posted on July 16, 2025, and responses are due by August 4, 2025.
This is a formal solicitation (SOLICITATION) and is currently active. Contractors should review the three attachments provided on the SAM.gov opportunity page for detailed specifications, terms, and submission instructions. No set-aside requirements or special considerations are specified in the available information. The procurement is expected to maintain consistent requirements and objectives throughout the contract lifecycle, focusing on the reliable supply of Sorafenib Tablets to meet federal healthcare needs.
For further details and to access the solicitation documents, contractors are encouraged to visit the official notice at https://sam.gov/opp/882c755e6b18493985dba7c3939601d8/view.